Our vision at Varian is “A world without fear of cancer.” We want to take a moment and explain what this means in Africa. With over a million new cancer cases per annum, the cancer burden is fast becoming a priority across the African continent.1
The high mortality rate is even more alarming. Current forecasts predict almost 1.5 million cancer-related deaths in 2040, a 106% increase compared to 2018. It is our duty to flatten this curve and prevent a humanitarian crisis.2
There is a clear need for increased access to cancer care. The disparity when we compare access to care in Africa to high-income countries is stark. Radiotherapy is a key modality in cancer management, yet in many regions, it is not readily available to most of the patients who might benefit. By the International Atomic Energy Agency (IAEA) calculations, Africa is in need of over 1,000 new linear accelerators now and will need over 2,000 by 2040.
At Varian, we believe the only way to prevent cancer from becoming a humanitarian crisis is through the hard work of people living in and committed to Africa. Since 2015, we have invested in several regional headquarters employing clinical & engineering specialists dedicated to supporting the African cancer community. Varian is working closely with partners across Africa and beyond to develop and implement safe, effective, sustainable, and intelligent cancer solutions. We focus on capacity building, innovative financing, clinical implementation support, and new AI-driven technologies. Varian is purposefully driving our vision throughout the African continent.
We hope you will share our vision, as we drive for equity of care across Africa and towards a world without fear of cancer.
Field Vice President, Middle East and Africa Operations
Director, Africa Operations
- International Agency for Research on Cancer. 2020. IARC Cancer Today. Accessed March 30, 2021.
- International Agency for Research on Cancer. 2020. IARC Cancer Tomorrow. Accessed March 30, 2021.
Management in Africa:
Chris Cowley - Field Vice President, Middle East and Africa Operations
Kevin Massoudi - Head of Government Affairs and Market Development, Middle East, India & Africa.
José-Manuel Valentim – Director, Africa Operations
Mourad Belkheyar - Algeria Managing Director
Djalal Abdelhafid – Northern-East Africa Sales Manager
Ansu Dukuray - Western Africa Sales Manager
Mohamed Namir - Western Africa Sales Manager
Edwin Maina - Eastern Africa Sales Manager
The customer selected Halcyon as an additional radiotherapy machine, because it is fast and simple to use, while delivering high quality care.
Lagos University Teaching Hospital in Nigeria (LUTH) is now providing the city’s population with improved access to care, replacing an old linac and adding two more. Varian worked diligently with the National Sovereign Investment Authority (NSIA) and LUTH staff to deliver and install three latest-generation systems: two VitalBeam and one Halcyon.
République Démocratique du Congo
Replacing an old linear accelerator with a new Halcyon at the end of 2019; now providing advanced radiation therapy treatments to the patients of DRC as the only linac in the country.
Taking cancer care to the next level by selecting TrueBeam for its image- guided radiotherapy capability, with installati¬on completed in August 2020. This tech¬nology aims to provide a more precise curative treatment which targets the tumor and avoids healthy surrounding areas.
Education and Training
Our education and training mission is to ensure our customers are comprehensively educated to use our solutions confidently and safely to provide compassionate core for their patients.
Learning platform for Varian’s Customer: MyVarian – Webinar
Varian and the Community
The Varian teams are continually striving for a world without fear of cancer. We are proud to be working alongside partners of exceptional caliber.